CAT vs GLUE · P/E 48, rev $37.96B vs rev $13.2M
Caterpillar Inc (CAT) versus Monte Rosa Therapeutics Inc (GLUE) — a side-by-side from cached financials, not a winner call.
Caterpillar Inc (CAT) is a farm & heavy construction machinery company listed on NYSE. It is led by Jim Umpleby.
Monte Rosa Therapeutics Inc (GLUE) is a biotechnology company listed on NASDAQ.
Latest reported CAT revenue for 2026-06-30 was $37.96B. Net income was $6.14B. CAT currently screens at market cap $440.29B and trailing P/E 47.7.
Latest reported GLUE revenue for 2026-06-30 was $13.2M. Net income was -$87.9M. GLUE currently screens at market cap $1.56B.
CAT currently screens at market cap $440.29B and trailing P/E 47.7. GLUE currently screens at market cap $1.56B.
Not investment advice. Open the CAT and GLUE stock pages for the full models.
Not investment advice.